Family · Pharmaceutical analytical standards

Aprotinin

A small 58-amino-acid polypeptide that inhibits trypsin and other proteases, first isolated in 1930 from bovine glands and used since the 1960s to reduce bleeding in surgery, especially heart surgery. This family brings together the active ingredient and other impurities.

Did you know?Also known as BPTI, it is one of the most studied proteins ever: in 1977 it was the first to be simulated on a computer with molecular dynamics, and it was the first whose structure was solved by NMR.

Go to the active ingredient →

Structure not applicable: proteinActive ingredientAprotinin HydrochlorideCat. No. P-A178-001

ImpurityAprotinin Solution BRPCat. No. P-A178-002CAS 9087-70-1

Structure not applicable: biological materialImpurityTrypsin BRPCat. No. P-A178-003CAS 9002-07-7

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Structure not applicable: mixtureFor system suitabilityAprotinin for system suitability CRSEDQM code Y0001154Family Aprotinin

Structure not applicable: biological materialBiological preparationAprotinin solution BRPEDQM code A1250000Family Aprotinin

Structure not applicable: biological materialBiological preparationTrypsin BRPEDQM code T2600000Family Aprotinin

Structure not applicable: biological materialBiological preparationTrypsin for aprotinin assay BRPEDQM code Y0002311Family Aprotinin

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.

See our services Contact us